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Anesthetics such as isoflurane are commonly used to sedate experimental animals during
the induction of stroke. Since these agents are known to modulate synaptic excitability,
inflammation and blood flow, they could hinder the development and discovery of new
neuroprotection therapies. To address this issue, we developed a protocol for inducing
photothrombotic occlusion of cerebral vessels in fully conscious mice and tested two
potential neuroprotectant drugs (a GluN2B or α4β2 nicotinic receptor antagonist). Our
data show in vehicle treated mice that just 20min of exposure to isoflurane during stroke
induction can significantly reduce ischemic cortical damage relative to mice that were
awake during stroke. When comparing potential stroke therapies, none provided any level
of neuroprotection if the stroke was induced with anesthesia. However, if mice were
fully conscious during stroke, the α4β2 nicotinic receptor antagonist reduced ischemic
damage by 23% relative to vehicle treated controls, whereas the GluN2B antagonist had
no significant effect. These results suggest that isoflurane anesthesia can occlude the
benefits of certain stroke treatments and warrant caution when using anesthetics for
pre-clinical testing of neuroprotective agents.
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INTRODUCTION
Anesthetics are commonly used in humans undergoing neuro-
surgery and experimental animals subjected to various kinds
of ischemic stroke. Over the years there has been a growing
appreciation that anesthetics have widespread effects on neuronal
and vascular function. For example, inhaled anesthetics such as
isoflurane can augment GABA, glutamate and nicotinic neuro-
transmission, mitochondrial function, apoptosis, inflammation
and cortical blood flow (Eger, 1981;McPherson et al., 1994; Flood
et al., 1997; De Sousa et al., 2000; Yamakura and Harris, 2000;
Wu et al., 2012; Zhang et al., 2012; Hofacer et al., 2013; Kotani
and Akaike, 2013; Altay et al., 2014). This is a potential concern
for pre-clinical studies of cerebral neuroprotection since many
potential treatments target the same signaling pathways as those
affected by anesthesia. The effects of anesthesia on brain function
can last for hours, even after the animal regains consciousness
(Kapinya et al., 2002b; Saab et al., 2010), which raises the possibil-
ity that anesthesia could affect the outcome of a neuroprotection
study.
In order to address this question, one needs to compare poten-
tial therapies in a model of stroke that can be induced without
anesthesia. There are a few published studies that describe pro-
cedures for inducing stroke in awake animals using intracortical
endothelin injection or intra-arterial infusion of microspheres
(Demura et al., 1993; Gelb et al., 2002). While useful, these
methods require invasive procedures such as the implantation
of a brain cannula which can augment cerebral blood flow and
induce inflammation. In the present study we developed a proto-
col for inducing focal ischemic stroke in fully awake mice using
the photothrombotic method (Watson et al., 1985). An advan-
tage of this approach is that ischemic stroke can be targeted to a
specific brain region or artery (Nishimura et al., 2006; Schaffer
et al., 2006; Sigler et al., 2008) without extensive surgical training
or invasive procedures. Here we show that not only can isoflurane
anesthesia reduce the extent of ischemic damage after stroke, but
it can mask the protective effects of a stroke therapy.
MATERIALS AND METHODS
ANIMALS
One hundred and fifty-six adult (2–4 months old) male wild-
type and YFP-H line (Feng et al., 2000) mice with C57BL/6J
background were analyzed in this study. All experiments were
approved by the University of Victoria’s Animal Care Committee
and adhered to guidelines set by the Canadian Council for Animal
Care.
APPARATUS AND PROCEDURE FOR INDUCING STROKE
We used either a 20 or 200mW 532 nm diode laser (Beta
Electronics) for photothrombotic occlusion of surface vessels
(Figure 1) or targeted occlusion of the distal middle cerebral
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FIGURE 1 | Twenty minutes of isoflurane reduces the extent of
ischemic damage. (A) Picture of an awake freely moving mouse during
induction of photothrombotic stroke. (B) Confocal images of brain
sections 24 h after sham stroke procedure indicates little to no reactive
astrocytes (GFAP staining, left panel) or cell death (FJC, right panel)
near the cortical surface where the skull was thinned. We should note
that our positive controls (perforating the skull and surface vasculature
with the dental drill) indicated that GFAP and Fluoro-jade staining were
sensitive to revealing tell tale signs of cortical damage. Scale bar =
0.5mm. (C) Whole mount confocal images of surface vasculature
labeled with Evans blue dye 24 h after sham procedure or induction of
stroke in mice anesthetized with 1.5% isoflurane for 45min or without
(awake group). Scale bar = 1mm (D) Images showing coronal brain
sections stained with Fluorojade C for ischemic cell death. Scale
bar = 1mm. Scale bar for inset = 100μm (E) Quantitative analysis of
infarct volume 24h after stroke. ∗p ≤ 0.05.
artery (MCA, Figure 2). The laser was focused onto the pol-
ished end of an unjacketed 1mm plastic optical fiber (Edmund
Scientific, 02534) mounted in an FC-style optical connector
(Thorlabs, 3012662-1050) using an 18mm focal length FC com-
patible collimator assembly (Thorlabs, F280FC-A). Output power
at the fiber tip was 12mW (15.29mW/mm2) for the 20mW laser.
For the 200mW laser, a neutral density filter was used to attenu-
ate the laser output power from 104 to 25mW (31.85mW/mm2)
at the fiber tip. The polished output end of the fiber was mounted
in a customized male Luer connector, which mated with a corre-
sponding female Luer connector cemented to the skull.
In order to prepare mice for the induction of stroke on the
following day (to install the headcap for the fiber optic attach-
ment), all animals were anaesthetized with 1.5% isoflurane mixed
with medical air (20% Oxygen, 80% Nitrogen) at a flow rate
of 0.7L/min. Since prolonged exposure to isoflurane anesthesia
(3 h) can be neuroprotective (Kapinya et al., 2002b), we restricted
surgery to 15–20min duration. Body temperature was main-
tained at 37◦C during surgery using a rectal thermoprobe and
a temperature feedback regulator. For non-specific photothrom-
botic occlusion of surface vessels (see Figure 1), a 2mm diameter
circular region of skull overlying the right forelimb somatosen-
sory cortex was thinned using a high speed dental drill. For
targeted distal MCA occlusion (Figure 2), a branch of the dis-
tal MCA in the right hemisphere (4mm lateral to bregma) was
first visualized by moistening the skull with sterile buffer. The
skull directly over a single branch of the MCA was thinned using
a 0.4mm diameter carbide burr (FG ¼ Henry Schein). Areas
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FIGURE 2 | Targeted ischemic stroke of the distal MCA in awake mice.
(A) Photomicrograph of distal MCA through the intact mouse skull. Adjacent
image shows skull after masking procedure to restrict photoactivation to the
distal MCA. Inset boxes show the segment of the MCA (labeled with Texas
red dextran) that will be subjected to photoactivation. Scale bar = 1mm.
Scale bar in boxed region = 0.2mm. (B) Images showing Rose Bengal dye
fluorescence in surface vessels following dye injection. Images and optical
density plot of dye fluorescence in vessels show that the dye circulated in
the blood for at least 45min. Scale bar = 0.2mm. (C) Transcranial laser
speckle contrast images of cortical blood flow at baseline and during 5, 15,
30, and 60min of photoactivation. Darker tones correspond to regions and
vessels with higher blood flow. Fluorescence image shown at 5min
illustrates selective photoactivation of Rose Bengal dye in a distal branch of
the MCA (2nd panel). Scale bar = 1mm. (D) Images show surface
vasculature labeled with Evans blue dye 24 h after sham operation or stroke
induction while awake. Scale bar = 3mm.
of skull adjacent to the thinned region of skull were masked
with permanent black marker. Control experiments indicated
that a photothrombotic stroke could not be induced through the
masked regions. A female luer lock connector (diameter 6mm)
was fixed to the skull with cyanoacrylate glue and dental cement.
All surgeries were performed blind to condition.Mice were briefly
warmed under a heat lamp and returned to their home cages.
Twenty four hours after the headcap was installed, animals
were randomly assigned to one of the experimental groups. To
enhance transparency of the skull and photoactivation, 20μl of
mineral oil was pipetted into the luer lock before connecting the
fiber optic cable. This was followed by an injection of 1% Rose
Bengal dye (110mg/kg, i.p.) dissolved in HEPES buffered ACSF.
Photoactivation was initiated using a 532 nm laser for 15min
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in our first set of experiments (Figure 1) or 60min for targeted
photothrombotic occlusion of the MCA (Figures 2–4). Mice that
did not show a permanent obstruction of the MCA (as shown
with Evans Blue dye 24 h after stroke) were excluded from the
study. Furthermore, 2 of 41 mice appeared to have a seizure 1–2 h
after stroke (1 treated with DHβE, the other vehicle) and were
immediately removed from the study.
DRUGS
Ninety minutes after the start of photothrombosis, mice
received a single injection (i.p.) of the GluN2B receptor antag-
onist Ro25-6981 (6mg/kg, Tocris Bioscience), the α4β2 spe-
cific nAChR antagonist dihydro-β-erythroidine hydrobromide
(3mg/kg DHβE, Tocris Bioscience) or 0.9% saline (vehicle).
An additional group of mice was injected with 3mg/kg DHβE
180min after stroke. Previous studies have shown that both drugs
readily cross the blood brain barrier and alter cortical excitability
(Liu et al., 2007; Brown et al., 2012).
EVANS BLUE ANGIOGRAMS AND ANALYSIS
Mice were administered 0.2mL of 4% Evans blue dye (i.v., dis-
solved in saline), briefly anesthetized with 2% isoflurane and
decapitated 5min later. Paraformaldehyde fixed brains were
imaged at 4× magnification (NA = 0.13) with an Olympus con-
focal microscope. We used 515 and 635 nm lasers to excite rose
bengal and Evans blue, respectively. Image stacks were collected
using a Kalman filter (average of 2 images) in 25μm z-steps at
640 × 640 pixels (5μm/pixel) with a pixel dwell time of 4μs.
INFARCT VOLUME ANALYSIS
Brains were sectioned at 50μm on a Leica vibratome in the coro-
nal plane. To quantify infarct volume 24 or 72 h after stroke, every
third section (150μm apart) was stained with 0.0001% Fluoro
Jade C (FJC) (Gu et al., 2012). Wide-field images of FJC stained
sections were collected with a 4× objective (NA = 0.13) using
a GFP filter set on an upright Olympus microscope. Using NIH
Image J software (version 1.44d) the infarct area showing dense
FIGURE 3 | The neuroprotective effects of an α4β2nAChR antagonist
(DHβE) are apparent only when stroke is induced without anesthesia.
(A) Diagram summarizing neuroprotection experiments. (B) Histogram
shows the effects of vehicle, DHβE and Ro25-6981 administered 1.5 h after
the initiation of photothrombosis on infarct volumes assessed 24 h after
stroke. Note that DHβE treatment was also examined 180min after stroke.
The number of mice in each group is indicated in each bar. ∗∗p ≤ 0.01.
(C) Anterior to posterior arrangement of representative coronal brain sections
stained with Fluorojade (C). Fluorescent (white) staining demarcates the
cerebral infarction. Scale bar = 1mm.
Frontiers in Neuroenergetics www.frontiersin.org April 2014 | Volume 6 | Article 1 | 4
Seto et al. Anesthesia masks neuroprotection
FIGURE 4 | The neuroprotective effects of DHβE in awake mice are
not explained by changes in penumbral blood flow. (A)
Photomicrograph showing the site of transcranial laser doppler recording
on the cortical surface (site marked with DiI, white arrow) 180min after
photo-occlusion of the MCA. Evans blue dye was injected to visualize
the ischemic territory. Scale bar = 2mm. (B) Representative transcranial
laser doppler recording of blood flow in the cortical penumbra (∼3.5mm
from site of distal MCA occlusion) in an awake mouse treated with
DHβE at 90min. Each data point represents a 5min average of perfusion.
Note the progressive drop in blood flow with the start of laser induced
photothrombosis (“laser on”) and that DHβE has no effect on cortical
perfusion. (C) Histogram showing the average percent change in
penumbral blood flow relative to baseline perfusion in awake animals
treated with vehicle (n = 4 mice) or DHβE (n = 5 mice). On average,
neither vehicle or DHβE injection altered blood perfusion in the penumbra
relative to pre-injection values.
fluorojade staining was outlined in each image by an observer
blind to condition. Infarct volume was calculated by summing
up the infarct area for each section multiplied by the distance
between each section (150μm).
LASER SPECKLE CONTRAST IMAGING
A 785 nm laser with 2mWoutput power (ThorLabs) was directed
at the cortex at a 30◦ angle (Zhang and Murphy, 2007; Armitage
et al., 2010). Blood flow was assessed by collecting 50 images
(696 × 520 pixels, 6.4μm/pixel) with 5–10ms exposure over a 5 s
period. Images were processed with a variance filter (radius = 1)
and then averaged together. A single image showing the standard
deviation was generated by taking the square root of the averaged
(variance processed) image. To correct for uneven illumination,
the standard deviation image was then divided by the mean of all
the raw images.
TRANSCRANIAL LASER DOPPLER RECORDINGS IN AWAKE MICE
A 0.5mm plastic fiber optic coupled to a laser doppler blood flow
monitor (Moor Instruments, moorVMS-LDF1) was threaded
inside a 20 gauge cannula (attached to the Luer lock on the skull)
and fixed in place with cyanoacrylate glue. Perfusion measure-
ments were collected at 10Hz over 150min period. Perfusion
measurements were typically 3–4mm posterior and medial from
the segment of MCA that was photo-activated. This cortical
region was at the interface between ischemic and non-ischemic
territory and hence denoted as “penumbra.” After 10min of
baseline measurements, stroke was initiated as described above.
Ninety minutes later, mice were injected with DHβE (3mg/kg)
or vehicle. Laser Doppler data were importing into IGOR Pro
(Wavemetrics, Eugene OR) and processed with a differentia-
tion algorithm followed by manual thresholding and binomial
smoothing (radius = 3) to help eliminate movement related data
artifacts. Perfusion values for each experiment were generated
by taking the average perfusion over a 10min period before the
induction of stroke, before injection (see Figure 4C, “pre-inject”)
or 5–15 after injection (“post-inject”).
STATISTICS
The effects of anesthesia and drug treatment were assessed
using an Analysis of Variance (ANOVA). Statistical comparisons
between groups were conducted using independent samples t-
tests. A Bonferroni correction was used for multiple unplanned
post-hoc comparisons. Based on preliminary variances using this
new model of stroke (assuming a significance level of 0.05 for a 2-
sided test, 80% power), we calculated that a sample size of at least
6 mice was necessary for experiment 1 where regional photoac-
tivation of somatosensory cortex was employed, whereas 9 mice
were needed for experiments using targeted MCA occlusion. A
Chi-squared analysis was used to test for significant differences
in stroke success and mortality rates. Data are presented as the
mean ± s.e.m.
RESULTS
In our first set of experiments, we used the photothrombotic
method to regionally occlude cortical surface vessels over the
primary forelimb somatosensory cortex (Figure 1A). Mice were
randomly assigned to receive either sham stroke (laser expo-
sure without dye injection or vice versa) or stroke while awake
(n = 7) or anesthetized with 1.5% isoflurane for 20 (n = 9) or
45min. Consistent with previous studies (Brown et al., 2009;
Grutzendler et al., 2011), thinning the skull or exposure to the
laser in sham operates did not induce reactive gliosis or cell death
near the cortical surface (n = 3, Figure 1B). As shown in surface
angiograms (Figure 1C) and Fluoro-Jade C stained brain sections
(Figure 1D), mice that were awake during stroke had a signifi-
cantly larger infarction (Figure 1E) than those anesthetized for 20
[t(7) = 2.04, p < 0.05] or 45min [t(9) = 2.72, p < 0.05]. Control
experiments imaging the spread of light from the fiber optic tip
ruled out the possibility that larger infarcts in awake ambulatory
mice was caused by subtle movement of the fiber optic attach-
ment and hence a greater area of photoactivation. Furthermore by
measuring Rose Bengal fluorescence in the blood plasma 20min
after injection, we determined that anesthesia did not signifi-
cantly affect its absorption into the bloodstream [t(15) = 0.31,
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p = 0.38]. These results demonstrate that even brief exposure to
isoflurane during stroke induction reduces the extent of ischemic
damage.
In humans, focal ischemic stroke typically involves a thrombo-
embolic occlusion of a specific segment of the MCA rather than
simultaneous generation of thrombotic clots in many penetrating
arterioles and micro-vessels over a cortical region (Carmichael,
2005; Jackman et al., 2011). Therefore to create a more realistic
model of ischemic stroke that could be used for neuroprotec-
tion studies, we restricted photoactivation to a single segment
of the distal MCA by first thinning a 0.4mm diameter region
of skull directly over the MCA and then masking adjacent areas
of the skull (Figure 2A). Consistent with previous studies that
have varied occlusion duration (Morancho et al., 2012), our pilot
experiments indicated that 60min of photoactivation, but not
15–30min (n = 6 mice) was required to reliably induce a per-
manent MCA occlusion. Longer periods of photoactivation were
made possible by the fact that dye circulated in the blood for
at least 45min after injection (Figure 2B). Laser speckle imag-
ing confirmed that blood flow was progressively reduced in
branches downstream of the MCA after the start of photoacti-
vation (Figure 2C). In order to illustrate the extent of ischemic
cortical tissue in the right hemisphere, Evans blue dye was injected
24 h after stroke (Figure 2D). Dye injection was useful for veri-
fying the presence of a permanent occlusion which was evident
by the absence of circulating dye near the site of MCA photoac-
tivation. Our success rate for inducing targeted MCA stroke in
awake vs. anesthetized animals was 91.5 and 80.0% respectively
(χ2 = 1.18, p > 0.05). The mortality rate was 5.6% for awake
mice and 2.2% for anesthetized mice (χ2 = 4.68, p < 0.05). It
should be noted that mice subjected to stroke while awake did
not show any overt signs of pain or distress such as vocalizations,
head scratching or aggressiveness. Interestingly, all mice with a
confirmed permanent MCA occlusion (verified post-mortem)
showed a reduction in ambulatory behavior at the time of pho-
toactivation. This behavioral pattern was useful to provide real
time information about the success of the stroke procedure.
Since distal MCA occlusion is often used in neuroprotection
studies, we asked whether the efficacy of a stroke therapy depends
on whether the stroke was induced in an awake or anesthetized
animal. Accordingly, mice that were awake or anesthetized with
isoflurane (1.5% in air) for 20 or 60min were given either a
single intraperitoneal injection of a GluN2B receptor antagonist
Ro 25-6981 (6mg/kg), an α4β2 nicotinic acetylcholine receptor
(nAChR) antagonist DHβE (3mg/kg) or vehicle 90min after the
start of the MCA occlusion (Figure 3A). We reasoned that since
ischemia stimulates glutamate and acetylcholine release (Dirnagl
et al., 1999; Kiewert et al., 2010), and that isoflurane can alter glu-
tamate receptor signaling and block α4β2 nAChRs (Flood et al.,
1997; Yamakura and Harris, 2000), it is possible that the neuro-
protective effects of these drugs could have been missed in pre-
vious studies. Consistent with our first set of experiments, mice
that were awake during stroke induction and treated with vehicle
had significantly larger infarcts than vehicle treated mice anes-
thetized for 20 [t(17) = 3.65, p = 0.001] or 60min [t(19) = 2.52,
p = 0.01; Figures 3B,C see Table 1 for infarct details]. The extent
of ischemic damage did not expand beyond the first 24 h, given
that there was no difference between infarct volumes measured at
24 vs. 72 h in anesthetized mice [1 day= 13.4± 1.1mm3 vs. 3 day
infarct volume = 12.8 ± 1.2mm3; t(19) = 0.31, p = 0.38]. With
respect to stroke treatments, none had any impact on infarct vol-
ume in mice that were anesthetized for either 20 [F(2, 25) = 1.01,
p = 0.38] or 60min [F(2, 26) = 0.31, p = 0.73] during the induc-
tion of stroke (Figure 3B). The absence of a neuroprotective effect
with Ro 25-6981 treatment (in anesthetized mice) is consistent
with previous studies (Liu et al., 2007; Sun et al., 2008). However
there was a significant effect of drug treatment if the stroke
was induced while awake [F(2, 26) = 3.82, p < 0.05]. Specifically,
DHβE (but not Ro 25-6981) treatment 90min after stroke was
highly effective in reducing the extent of ischemic damage rel-
ative to awake mice treated with saline [t(17) = 2.83, p < 0.01;
Figures 3B,C]. There was a trend toward smaller infarcts in an
additional group of awake mice treated with DHβE 180min after
occlusion [t(20) = 1.66, p = 0.05; Figure 3B]. These data show
that just 20min of exposure to isoflurane during stroke induction
can mask the benefits of a neuroprotection therapy.
In order to determine whether the neuroprotective effects of
DHβE in awake mice could be explained by increased blood
flow in the cortical penumbra, we transcranially recorded blood
flow in awake mice using laser doppler flowmetry (Figures 4A,B).
Table 1 | Summary of ischemic damage from each experimental group measured 24h after targeted occlusion of the MCA.
Condition Drug treatment No. of mice Total (mm3) Cortex (mm3) Striatum (mm3)
20min ISO Vehicle 9 11.7±1.00 11.6±0.98 0.1± 0.06
20min ISO DHβE 9 11.7±0.97 11.6±0.95 0.1± 0.05
20min ISO Ro25-6981 10 13.6±1.08 13.4±1.05 0.2± 0.12
60min ISO Vehicle 11 13.4±1.02 12.9±1.02 0.5± 0.25
60min ISO DHβE 9 11.9±1.41 11.6±1.31 0.3± 0.18
60min ISO Ro25-6981 9 12.5±1.62 11.8±1.35 0.7± 0.36
Awake Vehicle 10 17.2±1.12 16.4±0.79 0.8± 0.51
Awake DHβE 9 13.3±0.78 13.0±0.75 0.3± 0.09
Awake Ro25-6981 10 15.9±1.06 15.1±0.89 0.8± 0.23
Awake DHβE (3 h) 12 14.7±0.97 14.2±1.00 0.5± 0.21
Unless indicated, all drug treatments were administered 90min after the initiation of photothrombosis. All values are expressed as the mean ± s.e.m.
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Our analysis indicated that blood flow in the cortical penum-
bra was reduced by 44 ± 17% in vehicle and 50 ± 10%
in DHβE treated mice 90min after initiating photothrombo-
sis (Figures 4B,C). Treatment with DHβE did not significantly
alter blood flow in the penumbra relative to pre-injection lev-
els [Figure 4C, t(8) = 0.10, p = 0.46]. Furthermore, there were
no significant differences between saline and DHβE treated mice
in heart rate, respiration, blood gas/electrolyte concentrations or
blood pH (Table 2; n = 3 per group, p > 0.05 for all compar-
isons). Therefore the neuroprotective effects of DHβE in awake
mice are not explained by differences in penumbral blood flow or
global changes in several cardiovascular parameters.
DISCUSSION
The goal of the present study was to address two key ques-
tions: (1) does isoflurane anesthesia affect the extent of ischemic
stroke damage and (2) does the presence of isoflurane anesthe-
sia during stroke induction influence how well a neuroprotective
therapy appears to work? In order to investigate the first ques-
tion, we needed to develop a method for inducing stroke that
eliminated the need for anesthetics. Photothrombosis was a log-
ical choice for this given that the photosensitive dye could be
administered through an intraperioneal injection, while excita-
tion light could be delivered in a relatively non-invasive manner
through a fiber optic assembly. Our stroke protocol provides cer-
tain advantages over other commonly used experimental models
of focal ischemia (Longa et al., 1989). Most obvious is the elim-
ination of anesthesia which necessarily complicates the study of
how stroke or a neuroprotective treatment affects brain function,
circulation, and viability. Using un-anaesthetized animals also
opens up the possibility for examining how certain behavioral
states (sleep-wakefulness, satiety, exercise) can affect ischemic
damage. Another advantage is that no craniectomy is required
Table 2 | Physiological variables for drug experiments.
Awake—vehicle Awake—DHβE
pH 7.35±0.04 7.32±0.04
pCO2 (mmHg) 38.3±0.5 37.6±0.9
pO2 (mmHg) 89.6±3.8 95.3±7.8
HCO3 (mmol/L) 21.2±1.9 19.3±1.3
Na (mmol/L) 146±1.2 148±0.3
K (mmol/L) 6.2±0.3 5.6±0.2
Glucose (mmol/L) 240±26 204±38
Hematocrit (%) 46.3±2.3 45.2±2.0
Hemoglobin (g/dL) 15.8±2.3 15.4±0.7
O2 saturation (%) 94.2±1.4 92.0±1.7
Heart rate (bpm) 671±60 702±13
Breath rate (brpm) 151±16 183±16
Summary of physiological variables measured for drug therapy experiments.
Arterial blood was measured with an iSTAT CG8+ analyzer in un-anesthetized
mice 30min after administration of vehicle (n = 3) or DHβE (3mg/kg, n = 3).
Independent samples t-tests were used to compare groups. None of the vari-
ables were significantly different based on an alpha level of 0.01. Data are
presented as the mean ± s.e.m.
(Sugimori et al., 2004). This reduces the likelihood of craniec-
tomy induced hemorrhage and infection which can occur using
endothelin, thermal or mechanical occlusion of the MCA. More
practical advantages include the speed and ease with which the
stroke can be performed. In our lab, 3 different experimenters
were able to become proficient in this method of stroke in just
a few practice attempts. It should also be noted that the success
rate for inducing stroke was quite high, particularly in awake mice
(∼92%). Moreover, the co-efficient of variation for infarct vol-
umes in awake mice was 20.5%, suggesting that ischemic damage
was highly reproducible. Given some of the advantages outlined
above and the fact that targeted photothrombotic occlusion of the
MCA induces a penumbral region of reduced cortical blood flow
(see Figures 4B,C) (Yao et al., 2003), the present model could be
very useful for future neuroprotection studies.
As is the case with any model of stroke, there are limitations
and potential caveats with our approach. For one, our stroke
protocol still requires 15–20min of exposure to anesthesia to thin
the skull and attach the headcap. Since 3 h of isoflurane exposure
can affect stroke damage when induced 24 h later (Kapinya
et al., 2002a), there is a possibility that this exposure could
affect our results. However, this scenario seems unlikely since all
stroke groups (awake and anesthetized) were briefly exposed to
isoflurane and we were still able to detect a robust difference in
infarct volumes between awake and anesthetized mice. Second
the mice need to be tethered to the light weight fiber optic for
60min to ensure a permanent occlusion of the MCA. Therefore
it is possible that the fiber optic attachment might induce a stress
response or suppress some natural behaviors. While a potential
concern, we noticed in mice with a sham stroke or those few
instances where we were unsuccessful inducing the stroke, mice
showed normal exploratory and grooming behaviors during the
60min photoactivation period. It should also be noted that no
signs of cell death were observed in these mice, therefore any heat
associated with the laser was not sufficient to induce damage
which is consistent with previous studies using photothrombosis
(Sugimori et al., 2004; Sweetnam et al., 2012). Future iterations
of the present model could incorporate a 568 nm laser beam
(Sugimori et al., 2004) which more efficiently excites Rose Bengal
dye thereby reducing the time needed for photoactivation.
Another potential drawback is that photo-activation of Rose
Bengal dye generates singlet oxygen which directly damages the
vascular endothelium. This can lead to a rapidly progressing
infarct and vasogenic edema (Watson et al., 1985; Witte, 2010).
In humans these events are usually delayed a few hours, therefore
how closely photochemically induced ischemic damage models
the human condition is unclear (Witte, 2010). Furthermore, since
photothrombosis leads to a permanent irreversible occlusion, the
ability for many neuroprotectant drugs to promote re-perfusion
into the ischemic core may be limited.
Isoflurane was chosen in the present study because of its
widespread use in animal studies of stroke. However, isoflurane
and other inhaled anesthetics are well known to have multiple
effects on brain function. For example, isoflurane dose depen-
dently enhances GABAergic inhibitory post-synaptic currents,
while inhibiting glutamate release and AMPA mediated recep-
tor currents (Flood et al., 1997; Larsen and Langmoen, 1998;
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De Sousa et al., 2000; Saab et al., 2010; Kotani and Akaike,
2013). Isoflurane has also been shown to dilate cerebral vessels
and increase cortical blood flow (Eger, 1981; McPherson et al.,
1994; Iida et al., 1998). Given these diverse effects, it is plausible
that isoflurane could have intrinsic neuroprotective properties.
However, there is some debate in the literature on this issue. For
example, Nehls et al. (1987) reported that monkeys anesthetized
with isoflurane were more likely to suffer a stroke and resultant
hemiplegia than those treated with barbiturates. Contrasting with
these results, a retrospective study of patients undergoing car-
diac surgery revealed that those anesthetized with isoflurane had
a reduced risk of ischemic damage compared to those exposed to
enflurane or halothane (Michenfelder et al., 1987). Experimental
models of cerebral ischemia have found more consistent results in
that inhaled anesthetics such as isoflurane and sevoflurane atten-
uate stroke damage and reduce the severity of neurological deficits
(Warner et al., 1993; Sakai et al., 2007; Traystman, 2010; Zhou
et al., 2010). One potential limitation of past studies was that
the effects of isoflurane were not compared to an animal that
was completely free of anesthetic on the day stroke was induced.
Using both regional and targeted occlusion of cerebral vessels
in awake and anesthetized mice, our data support the hypothe-
sis that isoflurane can protect the brain from ischemic damage.
While we cannot extrapolate our findings to other anesthetics,
future studies utilizing the awake stroke model could help with
this determination.
With respect to our second objective, our data clearly indicate
that the efficacy of a drug therapy is in some cases dependent on
whether the stroke was induced with or without a general anes-
thetic. To our knowledge, this is the first study to show such
an effect. Moreover, no previous study has shown that block-
ing α4β2 nicotinic receptors in vivo can protect the brain from
ischemic damage. Given that isoflurane is a potent inhibitor of
α4β2 nAChRs (Yamakura and Harris, 2000), and that most pre-
clinical studies induce stroke with an anesthetic (often using
isoflurane), it is possible that the neuroprotective effects of an
α4β2 nAChR antagonist could have been missed in past studies.
Indeed, we too did not find any beneficial effects of DHβE if the
treatment was initiated in mice exposed to isoflurane anesthe-
sia during stroke induction. The mechanism through which the
α4β2 nAChR antagonist confers neuroprotection in awake mice
remains speculative but it was not a consequence of increased
collateral blood flow or changes in physiological variables such
as heart rate, respiration, blood gas or electrolyte concentrations.
Furthermore, a recent study demonstrated that systemic injection
of DHβE (at 3mg/kg) in adult C57BL6 mice has minimal
effect on core body temperature, thus ruling out hypothermia
as a cause (Rezvani et al., 2012). While beyond the scope of
the present study, future experiments directed at understand-
ing how α4β2 nAChRs modulate glutamate release/excitotoxicity
(Lambe et al., 2003), spreading depression (Sheardown, 1997;
Douglas et al., 2011), blood brain barrier permeability (Hawkins
et al., 2005) or inflammatory responses to ischemia should help
resolve this issue.
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